Capricor announces licensing of additional patent applications from Cedars-Sinai Center
Capricor Therapeutics announced it has added seven new patent applications to its existing Exclusive License Agreements with Cedars-Sinai Medical Center for technologies related to cardiosphere-derived cells and CDC-derived extracellular vesicles, including exosomes. January 16, 2018